Developing an Intervention Facilitating the Use of Eye Contact in Adults With Autism
NCT ID: NCT06924008
Last Updated: 2025-04-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
18 participants
OBSERVATIONAL
2025-07-07
2026-11-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Course of Face-to-face Interactions in Adults With Autism
NCT06925308
Autistic Eye Contact?
NCT06921876
Modulating Socially Adaptive Mirror System Functioning in Autism by Oxytocin
NCT03640156
Oxytocin Modulates Eye Gaze Behavior During Social Processing
NCT03293511
Sensory Intervention for Children With Autism
NCT06246487
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The research design chosen is qualitative research using triangulation by means of descriptive research in the form of semi-structured interviews and Intervention Mapping. The interviews have now taken place. These interviews, in addition to available scientific literature on eye contact in adults with autism, form the starting point for intervention development by means of Intervention Mapping. Intervention Mapping was chosen because the goal is to develop an intervention that will later be as effective as possible. This can be achieved by carefully weighing and substantiating the choices for the goal and the approach in the design phase. Intervention Mapping provides a theoretical basis for the intervention, which makes it more likely that the intervention will also work in practice. In addition, it provides a systematically described intervention and an implementation plan, making the intervention transferable and easier to put into practice. A major advantage of Intervention Mapping is that attention is paid to the way in which the results and effects of the project should be evaluated later, already in the development phase. In this way, Intervention Mapping contributes to increasing the effectiveness of the project. The aim of Intervention Mapping is to provide a framework for effective decision-making at every step of planning, implementation and evaluation. The Intervention Mapping protocol consists of six steps, with a number of tasks described for each step. Although Intervention Mapping is presented as a series of steps, it can be seen as iterative rather than linear. Programme planners switch back and forth between tasks and steps. The process is also cumulative: each step is based on previous steps.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Outpatient treatment within a specialized autism center in the Netherlands.
* Able to understand the topics to be discussed.
* Motivation to participate in research.
* Adults without DSM classification.
* Living in the Netherlands.
* Able to understand the topics to be discussed.
* Motivation to participate in research.
* Practicing psychiatrist, clinical psychologist or nurse specialist at an autism expertise center in the Netherlands.
* Living in the Netherlands.
* Motivation to participate in research.
Exclusion Criteria
* Use of alcohol and/or recreational drugs during the study.
* Mentally too unstable to participate in the study.
* Familiarity with treatment in the VGZ.
* No good command of the Dutch language.
* Use of alcohol and/or recreational drugs during the study.
\- No good command of the Dutch language.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dimence Groep
UNKNOWN
UMC Utrecht
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jos Boer
MSc
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nynke Boonstra, Professor
Role: STUDY_CHAIR
UMC Utrecht
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dimence Groep
Deventer, Overijssel, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Dimence Groep
Identifier Type: OTHER
Identifier Source: secondary_id
559903
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.